CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota. Show more

Location: 9201 West Broadway Avenue, Minneapolis, MN, 55445, United States | Website: https://www.cvrx.com | Industry: Medical Devices | Sector: Healthcare


Market Cap

178.1M

52 Wk Range

$4.30 - $18.55

Previous Close

$6.96

Open

$6.94

Volume

111,974

Day Range

$6.73 - $6.97

Enterprise Value

101.1M

Cash

102.7M

Avg Qtr Burn

-10.25M

Insider Ownership

4.26%

Institutional Own.

73.63%

Qtr Updated

03/31/25


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date